The Latest Dose

Clinical Trial Transformation Initiative (CTTI) announced on January 25, 2021, a new vision for clinical trial ecosystem and beyond, called Transforming Trials 2030. The pandemic has changed the way we perform clinical research, and many constituents have implemented new and efficient solutions, systems, and processes to conduct trials. CTTI members believe this passion and experience will help shape a future of smarter, faster research. In this episode, Kathy speaks with Dr. Pamela (Pam) Tenaerts, executive director at CTTI, about CTTI's vision for the future of clinical research, Transforming Trials 2030.

The pandemic has created a lot of disruption in clinical trials, but not all of it has been negative. From accelerating the adoption of decentralized trials and speeding up the delivery of vaccines, to telemedicine and mHealth playing bigger roles in patients' lives, opportunities have emerged to help us rediscover and recalibrate the way we perform clinical research. Many believe we can't go back to the old way of doing things – so who's leading the charge?

In this episode, we define what a movement is, learn how to be the "Dancing Man," and discuss why the #NoGoingBack mission is so critical to preserving the progress we've made in clinical research. To talk about why this is so important, we've brought on two leaders of the #NoGoingBack movement, Maimah Karmo and Craig Lipset, to share what it means to them.

Research shows that animals can improve the mental, physical, and emotional wellbeing of their human companions. From this strong bond comes the concept of therapy animals, or in this case, therapy dogs.

But what is a therapy dog, and how are they being used today?

In this episode, Kathy speaks with Children's Hospital Los Angeles and the Alliance of Therapy Dogs about their therapy dog programs, what it takes to become a volunteer, how dog therapy works, and more.

What is the role of innovation in clinical trials and why is it important? In this episode, Kathy speaks with Craig Serra, who works in clinical technology and innovation at Novartis, about different types of innovation and how they're used in the pharma industry.

Every year, the brightest minds in pharmaceuticals and clinical innovation put on their best black-tie attire for the life science industry's biggest event, the Prix Galien. In this episode, you'll learn about the history of the Prix Galien Awards, why it is considered the "Nobel Prize" for pharmaceutical research and development, and find out the new additions to its program from its chair and co-chair, Bruno Cohen and Dr. Michael Rosenblatt.

The pandemic heavily disrupted clinical trials, pushing us to rethink how we conduct clinical research. In this episode, Kathy invites Casey Orvin, SVP of pharmaceutics relationships at StudyKIK and honorary president of SCRS to talk about the future of decentralized trials and remote visits from the patient and site perspective.

In episode seven of The Latest Dose, our host Kathy Vandebelt invites two of Oracle's safety experts, Vice President of Safety Product Strategy, Bruce Palsulich, and Senior Director of Safety Strategy, Michael Braun-Boghos, to explore areas in pharmacovigilance where AI, automation, and touchless case processing are having a significant and positive impact on managing patient safety.

In this episode, host Kathy Vandebelt discusses how to get comfortable with the use of mobile technologies in clinical trials with our guest, Jennifer GoldSack. Jen serves as the Executive Director of the Digital Medicine Society (DiMe). She was also an Olympic athlete, and ties in her experience in the Olympics with the topic at hand – biometric monitoring.

In this episode, our host Kathy Vandebelt brings back Greater Gift and PopUp Star Founder, Jennifer Byrne, to talk this time specifically about the importance of giving back to clinical trial participants. In this interview, Jennifer dives into what Greater Gift is, her motivation for founding it, why it's important, and what they do to thank participants and other clinical research stakeholders.

For Clinical Trials Day, we want to shine a light on the patients and people who bring awareness to clinical research. To do this, Kathy Vandebelt interviews two industry veterans, Greater Gift and PopUp Star Founder Jennifer Bryne, and Oracle Health Sciences' Senior VP and General Manager Steve Rosenberg, about their personal experiences with clinical research, the history of Clinical Trials Day, what PopUp Star is, and how it's bringing awareness to clinical research.